General MedicationsINTRAMUSCULARGeneric
ATROPEN
ATROPINE
Standard Dose
EQ 2MG SULFATE/0.7ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ATROPEN is listed in Drugs@FDA under application 017106 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ATROPINE Form and strength SOLUTION;INTRAMUSCULAR - EQ 2MG SULFATE/0.7ML Sponsor MMT Submission history Latest submission status date: 2020-11-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview ATROPEN is listed in Drugs@FDA under application 017106 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ATROPINE Form and strength SOLUTION;INTRAMUSCULAR - EQ 2MG SULFATE/0.7ML Sponsor MMT Submission history Latest submission status date: 2020-11-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.